Genentech, Inc. - Strategy, SWOT and Corporate Finance Report

Genentech, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Genentech, Inc. (Genentech or ‘the company’), a subsidiary of Roche Group is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company’s medicines include Activase, Boniva Tablets, Cotellic, Erivedge, Fuzeon, Gazyva, Hemlibra, Invirase, Klonopin, Lucentis, Actemra, Nutropin AQ, Ocrevus, Tamiflu, Pegasys, Rituxan, Rocephin, Tecentriq, Polivy, Rozlytrek, Valium, Xeloda and Zelboraf. The company offers its products with a focus on the areas of oncology, immunology, neuroscience, metabolism, ophthalmology, and infectious disease. Genentech manages its manufacturing facilities and distribution center in California and Oregon, the US. The company is headquartered in South San Francisco, California, the US.

Scope

• Detailed information on Genentech, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
• Intelligence on Genentech, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Genentech, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Genentech, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Genentech, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Genentech, Inc.'s business structure, strategy and prospects.